# Stroke Volume Optimisation in Patients With Hip Fracture

> **NCT00444262** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 215 (actual)

## Conditions studied

- Hip Fractures

## Interventions

- **PROCEDURE:** hemodynamic optimisation guided using esophageal Doppler
- **DRUG:** VOLUVEN and others solute

## Key facts

- **NCT ID:** NCT00444262
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2010-11
- **Final completion:** 2011-03
- **Target enrollment:** 215 (ACTUAL)
- **Why stopped:** termination of the study due to difficulties to include patients
- **Last updated:** 2011-10-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00444262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00444262, "Stroke Volume Optimisation in Patients With Hip Fracture". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00444262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*